Patents by Inventor Richard Anthony Storey

Richard Anthony Storey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Hydrogen sulfate salt
    Patent number: 9562017
    Abstract: The present invention relates to Compound 1 hydrogen sulfate salt and solvates, crystalline forms and amorphous forms thereof, and to processes for their preparation.
    Type: Grant
    Filed: April 28, 2015
    Date of Patent: February 7, 2017
    Assignees: AsrtaZeneca AB, Array BioPharma Inc.
    Inventors: John DeMattei, Tsung-Hsun Chuang, Gorkhn Sharma-Singh, Paul Alfred Dickinson, Mohammed Pervez, Richard Anthony Storey, Christopher John Squire, James Gair Ford, Ronald John Roberts
  • Novel Hydrogen Sulfate Salt
    Publication number: 20160024018
    Abstract: The present invention relates to Compound 1 hydrogen sulfate salt and solvates, crystalline forms and amorphous forms thereof, and to processes for their preparation.
    Type: Application
    Filed: April 28, 2015
    Publication date: January 28, 2016
    Inventors: John DeMattei, Tsung-Hsun Chuang, Gorkhn Sharma-Singh, Paul Alfred Dickinson, Mohammed Pervez, Richard Anthony Storey, Christopher John Squire, James Gair Ford, Ronald John Roberts
  • Hydrogen sulfate salt
    Patent number: 9156795
    Abstract: The present invention relates to Compound 1 hydrogen sulfate salt and solvates, crystalline forms and amorphous forms thereof, and to processes for their preparation.
    Type: Grant
    Filed: May 3, 2012
    Date of Patent: October 13, 2015
    Assignees: Array BioPharma, Inc., Astrazeneca AB
    Inventors: John DeMattei, Tsung-Hsun Chuang, Christopher John Squire, Ronald John Roberts, Gorkhn Sharma-Singh, Mohammed Pervez, James Gair Ford, Richard Anthony Storey, Paul Alfred Dickinson
  • NOVEL HYDROGEN SULFATE SALT
    Publication number: 20140221443
    Abstract: The present invention relates to Compound 1 hydrogen sulfate salt and solvates, crystalline forms and amorphous forms thereof, and to processes for their preparation.
    Type: Application
    Filed: January 10, 2014
    Publication date: August 7, 2014
    Applicants: Astrazeneca AB, Array BioPharma Inc.
    Inventors: John DeMattei, Tsung-Hsun Chuang, Gorkhn Sharma-Singh, Paul Alfred Dickinson, Mohammed Pervez, Richard Anthony Storey, Christopher John Squire, James Gair Ford, Ronald John Roberts
  • Crystalline forms of 2-(2-flouro-4-iodophenylamino)-N-(2-hydroxyethoxy)-1,5-dimethyl-6-oxo-1,6-dihydropyridine-3-carboxamide
    Patent number: 8299076
    Abstract: Disclosed are crystalline forms of 2-(2-fluoro-4-iodophenylamino)-N-(2-hydroxyethoxy)-1,5-dimethyl-6-oxo-1,6-dihydropyridine-3-carboxamide useful in the treatment of hyperproliferative diseases, such as cancer and inflammation, in mammals, and inflammatory conditions. Also disclosed are methods of using such compounds in the treatment of hyperproliferative diseases in mammals and pharmaceutical compositions containing such compounds.
    Type: Grant
    Filed: May 17, 2006
    Date of Patent: October 30, 2012
    Assignees: Array Biopharma Inc., Astrazeneca AB
    Inventors: Allison L. Marlow, Eli Wallace, Jeongbeob Seo, Joseph P. Lyssikatos, Hong Woon Yang, Jim Blake, Richard Anthony Storey, Rebecca Jane Booth, John David Pittam, John Leonard, Mark Richard Fielding
  • NOVEL HYDROGEN SULFATE SALT
    Publication number: 20120253049
    Abstract: The present invention relates to Compound 1 hydrogen sulfate salt and solvates, crystalline forms and amorphous forms thereof, and to processes for their preparation.
    Type: Application
    Filed: May 3, 2012
    Publication date: October 4, 2012
    Inventors: John DeMattei, Tsung-Hsun Chuang, Christopher John Squire, Ronald John Roberts, Gorkhn Sharma-Singh, Mohammed Pervez, James Gair Ford, Richard Anthony Storey, Paul Alfred Dickinson
  • NOVEL HYDROGEN SULFATE SALT
    Publication number: 20100016393
    Abstract: The present invention relates to Compound 1 hydrogen sulfate salt and solvates, crystalline forms and amorphous forms thereof, and to processes for their preparation.
    Type: Application
    Filed: December 12, 2006
    Publication date: January 21, 2010
    Inventors: John DeMattei, Tsung-Hsun Chuang, Christopher John Squire, Ronald John Roberts, Gorkhn Sharma-Singh, Mohammed Pervez, James Gair Ford, Richard Anthony Storey, Paul Alfred Dickinson
  • TOSYLATE SALT OF 6- (4-BR0M0-2-CHL0R0PHENYLAMIN0) -7-FLUORO-N- (2-HYDROXYETHOXY) -3-METHYL-3H-BENZIMI DAZOLE- 5 - CARBOXAMIDE , MEK INHIBITOR USEFUL IN THE TREATMENT OF CANCER
    Publication number: 20090030058
    Abstract: The present invention relates to a tosylate salt of Compound 1 and polymorphs thereof, in particular crystalline and amorphous forms of Compound 1 tosylate salt, and methods of preparation thereof. Pharmaceutical compositions containing these salts as active ingredient, their use in the manufacture of medicaments for use in the treatment and/or prophylaxis of proliferative disease states, such as cancer, in the human or animal body, and their use in methods for the treatment and/or prophylaxis of proliferative disease states, such as cancer, in the human or animal body are also described.
    Type: Application
    Filed: December 18, 2006
    Publication date: January 29, 2009
    Inventors: Mohammed Pervez, Ronald John Roberts, Christopher John Squire, Richard Anthony Storey
  • 4- (4-Bromo-2-Fluoroanilino) -6- Methoxy-7- (1-Methylpiperidin-4-Ylmethoxy) Quinazoline Monohydrate
    Publication number: 20080312261
    Abstract: The present invention relates to a ZD6474 monohydrate, to processes for the preparation of a ZD6474 monohydrate, to pharmaceutical compositions comprising a ZD6474 monohydrate as the active ingredient, to the use of a ZD6474 monohydrate in the manufacture of medicaments for use in the production of antiangiogenic and/or vascular permeability reducing effects in warm-blooded animals such as humans, and to the use of a ZD6474 monohydrate in methods for the treatment of disease states associated with angiogenesis and/or increased vascular permeability, such as cancer, in warm-blooded animals such as humans.
    Type: Application
    Filed: September 27, 2006
    Publication date: December 18, 2008
    Inventors: Rebecca Jane Booth, Brian Roger Meyrick, Zakariya Patel, Richard Anthony Storey
  • Heterocyclic Inhibitors of Mek and Methods of Use Thereof
    Publication number: 20080280957
    Abstract: Disclosed are MEK inhibitors useful in the treatment of hyperproliferative diseases, such as cancer and inflammation, in mammals, and inflammatory conditions. Also disclosed are methods of using such compounds in the treatment of hyperproliferative diseases in mammals and pharmaceutical compositions containing such compounds.
    Type: Application
    Filed: May 17, 2006
    Publication date: November 13, 2008
    Applicants: ARRAY BIOPHARMA, INC., ASTRAZENECA AB
    Inventors: Allison L. Marlow, Eli M. Wallace, Jeongbeob Seo, Joseph P. Lyssikatos, Hoog Woon Yang, James Blake, Richard Anthony Storey, Rebecca Jane Booth, John David Pittam, John Leonard, Mark Richard Fielding
  • Process
    Patent number: 7132549
    Abstract: The present invention provides an improved process for the preparation of a polymorph of eletriptan hemisulphate.
    Type: Grant
    Filed: May 24, 2004
    Date of Patent: November 7, 2006
    Assignee: Pfizer Inc.
    Inventors: Julian Aranda-Martinez, Catherine Dunne, Juergen Friedrich Kleinschroth, Julie Ann MacRae, Richard Anthony Storey, Ellen Johanna Weilbacher
  • Crystalline therapeutic agent
    Publication number: 20040235857
    Abstract: A novel solid form of sildenafil citrate wherein the ratio of sildenafil: citrate is 1:0.5.
    Type: Application
    Filed: January 22, 2004
    Publication date: November 25, 2004
    Applicant: Pfizer Inc
    Inventors: Christopher Ian Dallman, Andrew Kevern Hills, James Gerard McGovern, Richard Anthony Storey
  • (7-(3-carboxyphenyl)-4-chloroisoquinolin-1-yl)guanidine
    Patent number: 6645979
    Abstract: The invention described herein relates to a process for the preparation of (7-(3-carboxyphenyl)-4-chloroisoquinolin-1-yl)guanidine (I), intermediates thereto and new forms and formulations thereof, including the zwitterion monohydrate of (I), suitable for pharmaceutical use.
    Type: Grant
    Filed: October 29, 2001
    Date of Patent: November 11, 2003
    Assignee: Pfizer Inc.
    Inventors: Anne Bruckner, Michael Butters, Paul Vincent Fish, Michael Paul Fitzgerald, Julie Ann Macrae, Trevor Jack Newbury, Richard Anthony Storey
  • Crystalline therapeutic agent
    Patent number: 6420557
    Abstract: A polymorph of 1-{6-ethoxy-5-[3-ethyl-6,7-dihydro-2-(2-methoxyethyl)-7-oxo-2H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-pyridylsulfonyl}-4-ethylpiperazine.
    Type: Grant
    Filed: July 26, 2001
    Date of Patent: July 16, 2002
    Assignee: Pfizer Inc.
    Inventors: Laurence James Harris, Richard Anthony Storey, Albert Shaw Wood
  • (7-(3-Carboxyphenyl)-4-chloroisoquinolin-1-yl)guanidine
    Publication number: 20020077336
    Abstract: The invention described herein relates to a process for the preparation of (7-(3-carboxyphenyl)-4-chloroisoquinolin-1-yl)guanidine (I), intermediates thereto and new forms and formulations thereof, including the zwitterion monohydrate of (I), suitable for pharmaceutical use.
    Type: Application
    Filed: October 29, 2001
    Publication date: June 20, 2002
    Inventors: Anne Bruckner, Michael Butters, Paul Vincent Fish, Michael Paul Fitzgerald, Julie Ann Macrae, Trevor Jack Newbury, Richard Anthony Storey
  • Crystalline therapeutic agent
    Publication number: 20020040140
    Abstract: A polymorph of 1-{6-ethoxy-5-[3-ethyl-6,7-dihydro-2-(2-methoxyethyl)-7-oxo-2H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-pyridylsulfonyl}-4-ethylpiperazine.
    Type: Application
    Filed: July 26, 2001
    Publication date: April 4, 2002
    Inventors: Laurence James Harris, Richard Anthony Storey, Albert Shaw Wood